Item Type | Name |
Academic Article
|
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.
|
Concept
|
HIV Seropositivity
|
Concept
|
HIV Seroprevalence
|
Concept
|
HIV-1
|
Concept
|
HIV Antibodies
|
Concept
|
HIV Protease Inhibitors
|
Concept
|
HIV Reverse Transcriptase
|
Concept
|
HIV
|
Concept
|
HIV Core Protein p24
|
Concept
|
HIV Infections
|
Concept
|
Anti-HIV Agents
|
Academic Article
|
HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
|
Academic Article
|
Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals.
|
Academic Article
|
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.
|
Academic Article
|
Comorbid Pain Syndromes in HIV-Associated Peripheral Neuropathy.
|
Academic Article
|
A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team.
|
Academic Article
|
Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy.
|
Academic Article
|
HIV rounds at Cornell: selected neurologic complications of HIV disease.
|
Academic Article
|
Diaphragmatic paralysis due to isolated phrenic neuropathy in an HIV-infected man.
|
Academic Article
|
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.
|
Academic Article
|
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir.
|
Academic Article
|
Brain morphometric correlates of metabolic variables in HIV: the CHARTER study.
|
Academic Article
|
Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy.
|
Academic Article
|
A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain.
|
Academic Article
|
Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review.
|
Academic Article
|
The pathogenesis of diffuse infiltrative lymphocytosis syndrome: an AIDS-related peripheral neuropathy.
|
Academic Article
|
Myopathy associated with human immunodeficiency virus (HIV) but not with zidovudine.
|
Academic Article
|
Oxandrolone in AIDS-wasting myopathy.
|
Academic Article
|
JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy.
|
Academic Article
|
HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir.
|
Academic Article
|
Antiretroviral rounds. First holiday was a disaster: should she take another?
|
Academic Article
|
Low atazanavir concentrations in cerebrospinal fluid.
|
Academic Article
|
Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy.
|
Academic Article
|
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.
|
Academic Article
|
Clinical factors related to brain structure in HIV: the CHARTER study.
|
Academic Article
|
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.
|
Academic Article
|
Pilot study of intravenous immunoglobulin in HIV-associated myelopathy.
|
Academic Article
|
HIV-associated PML: changing epidemiology and clinical approach.
|
Academic Article
|
Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.
|
Academic Article
|
Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity.
|
Academic Article
|
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.
|
Academic Article
|
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.
|
Academic Article
|
Etravirine in CSF is highly protein bound.
|
Academic Article
|
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.
|
Academic Article
|
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
|
Academic Article
|
Managing HIV peripheral neuropathy.
|
Academic Article
|
Neurocognitive impairment in HIV-infected individuals with previous syphilis.
|
Academic Article
|
Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial.
|
Academic Article
|
HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment.
|
Academic Article
|
AIDS-associated vacuolar myelopathy.
|
Academic Article
|
Controlling neuropathic pain in HIV.
|
Academic Article
|
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.
|
Academic Article
|
Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study.
|
Academic Article
|
Apolipoprotein E e4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.
|
Academic Article
|
Therapeutic amprenavir concentrations in cerebrospinal fluid.
|
Academic Article
|
Neuromuscular complications in HIV: effects of aging.
|
Academic Article
|
Clinical variables identify seronegative HCV co-infection in HIV-infected individuals.
|
Academic Article
|
Optimizing measures of HIV-associated neuropathy.
|
Academic Article
|
Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy.
|
Academic Article
|
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort.
|
Academic Article
|
Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
|
Academic Article
|
A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy.
|
Academic Article
|
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people.
|
Academic Article
|
Neuromuscular complications of human immunodeficiency virus infection.
|
Academic Article
|
Neuromuscular complications of HIV infection and its treatment.
|
Academic Article
|
Human immunodeficiency virus wasting syndrome may represent a treatable myopathy.
|
Academic Article
|
Neuromuscular complications of the human immunodeficiency virus type 1 infection.
|
Academic Article
|
The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy.
|
Academic Article
|
Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors.
|
Academic Article
|
Neurologic manifestations of HIV infection.
|
Academic Article
|
Human immunodeficiency virus-associated myopathy: analysis of 11 patients.
|
Academic Article
|
Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.
|
Academic Article
|
White matter damage, neuroinflammation, and neuronal integrity in HAND.
|
Academic Article
|
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090.
|
Academic Article
|
Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
|
Academic Article
|
Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
|
Academic Article
|
Neuromuscular complications in HIV.
|
Academic Article
|
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy.
|
Academic Article
|
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
|
Academic Article
|
HIV neuromuscular disease and mitochondrial function.
|
Academic Article
|
A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy.
|
Academic Article
|
HIV neuropathy natural history cohort study: assessment measures and risk factors.
|
Academic Article
|
Clinical validation of the NeuroScreen.
|
Academic Article
|
HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter.
|
Academic Article
|
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning.
|
Academic Article
|
Neuromuscular diseases associated with HIV-1 infection.
|
Academic Article
|
HIV-associated neuropathic pain: epidemiology, pathophysiology and management.
|
Academic Article
|
Role of metabolic syndrome components in HIV-associated sensory neuropathy.
|
Academic Article
|
Lower CSF A? is Associated with HAND in HIV-Infected Adults with a Family History of Dementia.
|
Academic Article
|
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials.
|
Academic Article
|
Neuromuscular complications of human immunodeficiency virus infection.
|
Academic Article
|
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.
|
Academic Article
|
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals.
|
Academic Article
|
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change.
|
Academic Article
|
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.
|
Academic Article
|
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.
|
Academic Article
|
Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
|
Academic Article
|
The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.
|
Academic Article
|
Understanding the etiology and management of HIV-associated peripheral neuropathy.
|
Academic Article
|
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.
|
Academic Article
|
Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy.
|
Academic Article
|
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection.
|
Academic Article
|
NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
|
Academic Article
|
CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.
|
Academic Article
|
Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
|
Academic Article
|
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.
|
Academic Article
|
Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.
|
Academic Article
|
Neuromuscular complications of HIV infection.
|
Academic Article
|
Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States.
|
Academic Article
|
Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.
|
Academic Article
|
Cerebellar degeneration associated with human immunodeficiency virus infection.
|
Academic Article
|
Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
|
Academic Article
|
Human immunodeficiency virus infection in Northern Ireland 1980-1989.
|
Academic Article
|
Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study Team.
|
Academic Article
|
Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.
|
Academic Article
|
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
|
Academic Article
|
Peripheral neuropathy in HIV disease.
|
Academic Article
|
An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.
|
Academic Article
|
Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy.
|
Academic Article
|
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients.
|
Academic Article
|
Myopathy in HIV infection.
|
Academic Article
|
AIDS and AIDS-treatment neuropathies.
|
Academic Article
|
MR findings in AIDS-associated myelopathy.
|
Academic Article
|
A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291.
|
Academic Article
|
AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid.
|
Academic Article
|
Controlling Neuropathic Pain in HIV.
|
Academic Article
|
Inflammatory pseudotumor associated with HIV, JCV, and immune reconstitution syndrome.
|
Academic Article
|
Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy.
|
Academic Article
|
Memantine for AIDS dementia complex: open-label report of ACTG 301.
|
Academic Article
|
Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.
|
Academic Article
|
Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN.
|
Academic Article
|
A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy.
|
Academic Article
|
Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals.
|
Academic Article
|
Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy.
|
Academic Article
|
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.
|
Academic Article
|
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
|
Academic Article
|
Peripheral neuropathy in HIV: prevalence and risk factors.
|
Academic Article
|
Neurocognitive impact of substance use in HIV infection.
|
Academic Article
|
Chronic pain disorders in HIV primary care: clinical characteristics and association with healthcare utilization.
|
Academic Article
|
Hypnosis for treatment of HIV neuropathic pain: a preliminary report.
|
Academic Article
|
Reply to Haddow et al.
|
Academic Article
|
The Quantitative Analgesic Questionnaire: A Tool to Capture Patient-Reported Chronic Pain Medication Use.
|
Academic Article
|
Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.
|
Academic Article
|
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.
|
Academic Article
|
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
|
Academic Article
|
Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy.
|
Academic Article
|
Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
|
Academic Article
|
HIV, antiretrovirals, and peripheral neuropathy: A moving target.
|
Academic Article
|
A phase I/II trial of nimodipine for HIV-related neurologic complications.
|
Academic Article
|
Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.
|
Academic Article
|
Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.
|
Academic Article
|
Outbreaks of syphilis in rural Texas towns, 1991-1992.
|
Academic Article
|
Peripheral neuropathy in HIV infection.
|
Academic Article
|
HIV-related neurocognitive impairment in the HAART era.
|
Academic Article
|
Diagnosis and management of HIV-associated neuropathy.
|
Academic Article
|
Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
|
Academic Article
|
Peripheral neuropathies associated with human immunodeficiency virus infection.
|
Academic Article
|
Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings.
|
Academic Article
|
Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients.
|
Academic Article
|
Neurologic manifestations of HIV infection.
|
Academic Article
|
Treatment of painful distal sensory polyneuropathy in HIV-infected patients with a topical agent: results of an open-label trial of 5% lidocaine gel.
|
Academic Article
|
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.
|
Academic Article
|
Problematic prescription opioid use in an HIV-infected cohort: the importance of universal toxicology testing.
|
Academic Article
|
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.
|
Academic Article
|
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.
|
Academic Article
|
Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons.
|
Academic Article
|
Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.
|
Academic Article
|
The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study.
|
Academic Article
|
Simplification of the research diagnosis of HIV-associated sensory neuropathy.
|
Academic Article
|
Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.
|
Academic Article
|
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV.
|
Academic Article
|
Lifetime suicidal ideation and attempt are common among HIV+ individuals.
|
Academic Article
|
Lower-extremity Dynamometry as a Novel Outcome Measure in a Double-blind, Placebo-controlled, Feasibility Trial of Intravenous Immunoglobulin (IVIG) for HIV-associated Myelopathy.
|
Academic Article
|
HIV neuropathy.
|
Academic Article
|
Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.
|
Grant
|
NEUROMUSCULAR DISORDERS IN HIV INFECTION AND ROLE OF AZT
|
Grant
|
MIDCAREER INVESTIGATOR AWARD IN NEURO-AIDS RESEARCH
|